AvalehtRVTY • NYSE
add
Revvity Inc
Viimane sulgemishind
90,50 $
Tänane vahemik
90,88 $ - 92,79 $
Aasta vahemik
87,70 $ - 129,50 $
Turuväärtus
10,84 mld USD
Keskmine maht
1,30 mln
P/E suhe
-
Dividendimäär
-
Põhibörs
NYSE
Börsiuudised
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
(USD) | märts 2025info | Y/Y muutus |
---|---|---|
Käive | 664,76 mln | 2,28% |
Põhitegevusega seonduv kulu | 294,36 mln | 4,33% |
Puhastulu | 42,24 mln | 62,37% |
Puhaskasumimarginaal | 6,35 | 58,75% |
Puhaskasum aktsia kohta | 1,01 | 3,06% |
EBITDA | 178,61 mln | −1,26% |
Tõhus maksumäär | 20,45% | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
(USD) | märts 2025info | Y/Y muutus |
---|---|---|
Sularaha ja lühiajalised investeeringud | 1,14 mld | −32,90% |
Kogu vara | 12,36 mld | −7,98% |
Kõik kohustused | 4,72 mld | −15,44% |
Kogu omakapital | 7,64 mld | — |
Emiteeritud aktsiate arv | 117,87 mln | — |
Hinna ja väärtuse suhe P/B | 1,41 | — |
Varade tasuvus | 1,64% | — |
Kapitali tasuvus | 1,85% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
(USD) | märts 2025info | Y/Y muutus |
---|---|---|
Puhastulu | 42,24 mln | 62,37% |
Põhitegevuse rahakäive | 128,16 mln | −13,15% |
Investeeringute raha | −6,38 mln | 64,92% |
Finantseerimise raha | −163,66 mln | −367,44% |
Raha ja raha ekvivalentide muutus | −25,76 mln | −130,28% |
Tasuta rahavoog | 151,22 mln | 12,02% |
Teave
Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines.
In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY. Wikipedia
Tegevjuht
Asutatud
1947
Veebisait
Töötajate arv
11 000